TABLE 5.
Clinical sensitivity and specificity of the ResistancePlus MG FleXible assay (RPMG Flex)a
| Assay | Matrix | Sensitivity (%) | % Correct assignment of MRMM | % Correct assignment of WT | Specificity (%) |
|---|---|---|---|---|---|
| RPMG Flex | Urine | 95 (19/20) | 100 (9/9) | 100 (10/10) | 100 (20/20) |
| MgPa-MagNAPure 24 | Urine | 95 (19/20) | NA | NA | 100 (20/20) |
| MgPa-NucliSENS easyMAG | Urine | 95 (19/20) | NA | NA | 100 (20/20) |
| RPMG Flex | All genital swab samples (n = 122) | 96 (55/57) | 89 (26/29) | 96 (25/26) | 98 (64/65) |
| MgPa-MagNAPure 24 | All genital swab samples (n = 122) | 82 (47/57) | NA | NA | 98 (64/65) |
| MgPa-NucliSENS easyMAG | All genital swab samples (n = 122) | 84 (48/57) | NA | NA | 98 (64/65) |
| RPMG Flex | Cervical swab (n = 63) | 95 (35/37) | 85 (17/20) | 100 (15/15) | 100 (26/26) |
| MgPa-MagNAPure 24 | Cervical swab (n = 63) | 76 (28/37) | NA | NA | 100 (26/26) |
| MgPa-NucliSENS easyMAG | Cervical swab (n = 63) | 78 (29/37) | NA | NA | 100 (26/26) |
| RPMG Flex | Vaginal swab (n = 27) | 100 (6/6) | 2/2 | 4/4 | 95 (20/21) |
| MgPa-MagNAPure 24 | Vaginal swab (n = 27) | 100 (6/6) | NA | NA | 95 (20/21) |
| MgPa-NucliSENS easyMAG | Vaginal swab (n = 27) | 100 (6/6) | NA | NA | 100 (21/21) |
| RPMG Flex | Female urethral swab (n = 11) | 100 (4/4) | 100 (2/2) | 100 (2/2) | 100 (7/7) |
| MgPa-MagNAPure 24 | Female urethral swab (n = 11) | 75 (3/4) | NA | NA | 100 (7/7) |
| MgPa-NucliSENS easyMAG | Female urethral swab (n = 11) | 75 (3/4) | NA | NA | 100 (7/7) |
| RPMG Flex | Male urethral swab (n = 21) | 100 (10/10) | 100 (5/5) | 100 (4/5) | 100 (11/11) |
| MgPa-MagNAPure 24 | Male urethral swab (n = 21) | 100 (10/10) | NA | NA | 100 (11/11) |
| MgPa-NucliSENS easyMAG | Male urethral swab (n = 21) | 100 (10/10) | NA | NA | 100 (11/11) |
a
NA, not applicable.